Comparison of Platelet Mass Index in On-Pump and Off-Pump Coronary Artery Bypass Surgery
Keywords:Platelet Mass Index, Coronary Artery, bypass, Off-Pump
Introduction: Platelet mass index (PMI) is calculated by multiplying platelet count and mean platelet volume (MPV). It demonstrates platelet activation and is thought to be associated with inflammation. Its importance for cardiac surgery has not yet fully been clarified. This study investigates whether there is a difference between PMI levels after on-pump and off-pump coronary artery bypass surgery and the relationship between early postoperative complications and PMI.
Method: In our hospital, 138 patients were included in the study retrospectively. The patients were divided into
2 groups: Group 1 (on-pump) with 80 patients (22 females,
58 males, mean age 61.54 ± 8.68) and Group 2 (off-pump) with 58 patients (15 females, 43 males, mean age 61.34 ± 10.04). In biochemical analysis, hemoglobin, platelet, white blood cell, and MPV values of the patients were evaluated in the biochemistry laboratory of our hospital with the blood taken preoperatively from the forearm veins and postoperatively on the first, third, and seventh days and, on average, after the first month.
Results: There was a statistically significant difference between postoperative first day thrombocyte (K/µL) (P = .005), postoperative first day PMI (P = .014), postoperative first day leukocyte (K/µL) (P = .001), postoperative first day Hb (g/dL) (P = .001), postoperative third day thrombocyte (K/µL) (P = .003), postoperative third day PMI (P = .031), postoperative third day leukocyte (K/µL) (P = .004), and postoperative seventh day leukocyte (K/µL) (P = .002). There was no meaningful relationship between PMI and early postoperative complications.
Conclusion: We think PMI is a more valuable indicator than MPV as an inflammation marker in cardiac surgery. In our opinion, PMI is a cheap and valuable inflammation marker that can be used in coronary surgery that can be obtained from routine hemogram test and can easily be evaluated.
Akpinar I, Sayin MR, Gursoy YC, Karabag T, Kucuk E, Buyukuysal MC, et al. 2014. Plateletcrit: a platelet marker associated with saphenous vein graft disease. Herz 39(1): 142-8.
Boos CJ, Lip GY. 2007. Assessment of mean platelet volume in coronary artery disease–what does it mean? Thromb Res. 120(1): 11-3.
Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. 2010. Mean platelet volume is a risk factor for venous thromboembolism: the tromso study, tromso, Norway. J Thromb Haemost. 8(1):157-62.
Çakmak AH, Enhoş A, Ertürk M, Kalkan KA, Satılmışoğlu HM, Gül M. 2016. Association between New Platelet Indices and Calcific Aortic Stenosis: Plateletcrit and Platelet to Lymphocyte Ratio. Van Med J. 23(4): 330-7.
Christen S, Finckh B, Lykkesfeldt J, Gessler P, Frese-Schaper M, Nielsen P, et al. 2005. Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation. Free Radic Biol Med. 38(10):1323–32.
Demir N, Peker E, Ece İ, Ağengin K, Bulan KA, Tuncer O. 2016. Is platelet mass a more significant indicator than platelet count of closure of patent ductus arteriosus? J Matern Fetal Neonatal Med. 29(12):1915-8.
Franco AT, Corken A, Ware J. 2015. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 126(5):582-8.
Girgin R, Cinar O, Bulut E, Akduman B, Mungan NA. 2018. The Role Of The Platelet Mass İndex (PMI) As A New Prognostic Factor İn Fourneir’s Gangrene. African Journal Of Urology. 24:226-32.
Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. 2004. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 35(7):1688-91.
Kahvecioglu D, Erdeve O, Akduman H, Ucar T, Alan S, Çakır U, et al. 2018. Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in the prematurity. Pediatr Neonatol. 59(1):53-7.
Korkmaz L, Baştuğ O, Ozdemir A, Korkut S, Karaca C, Akin MA, et al. 2017. The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass index. Curr Eye Res. 42(1):88-97.
Laffey JG, Boylan JF, Cheng DC. 2002. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 97(1):215–52.
Langer HF, Gawaz M. 2008. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost. 99(3): 480-6.
Lehmann S, Dieterlen MT, Flister A, Klaeske K, Jawad K, Garbade J, et al. 2019. Differences of early immunological responses in on-pump versus off-pump cardiac surgery. Perfusion. 34(5):399-407.
Li JY, Li Y, Jiang Z, Wang RT, Wang XS. 2014. Elevated mean platelet volume is associated with presence of colon cancer. Asian Pac J Cancer Prev. 15(23):10501-4.
Lisman T. 2018. Platelet–neutrophil interactions as drivers of inflammatory and thrombotic disease. Cell Tissue Res. 371(3):567-76.
Okur N, Buyuktiryaki M, Uras N, Oncel MY, Ertekin O, Canpolat FE et al. 2016. Platelet mass index in very preterm infants: can it be used as a parameter for neonatal morbidities? J Matern Fetal Neonatal Med. 29(19): 3218-22.
Omar M, Tanriverdi O, Cokmert S, Oktay E, Yersal O, Pilancı KN, et al. 2018. Turkish Descriptive Oncological Researches Group. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer. Clin Respir J. 12(3):922-29.
Paparella D, Yau TM, Young E. 2002. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 21(2):232-44.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107(3):499–511.
Wachowicz B, Morel A, Miller E, Saluk J. 2016. The physiology of blood platelets and changes of their biological activities in multiple sclerosis. Acta Neurobiol Exp (Wars). 76(4):269-81.
Yoon SS, Bang JH, Jeong SS, Jeong JH, Woo JS. 2017. Risk Factors of On-Pump Conversion during Off-Pump Coronary Artery Bypass Graft. Korean J Thorac Cardiovasc Surg. 50(5):355-62.
Zakkar M, Ascione R, James AF, Angelini GD, Suleiman MS. 2015. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 154:13-20.10. Zakkar M, Guida G, Suleiman MS, Angelini GD. 2015. Cardiopulmonary bypass and oxidative stress. Oxid Med Cell Longev. 2015:189863.
Zhang Z, Xu X, Ni H, Deng H. 2014. Platelet indices are novel predictors of hospital mortality in intensive care unit patients. J Crit Care 29(5):885.e1-6.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).